{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-006985","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2025-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.251457+00:00","generated_at":"2026-05-17T06:37:21.477348+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Phio stockholders approve 950,000-share increase to 2020 LTIP plan; adopt 3-year say-on-pay frequency","bullets":["All six director nominees elected with 84-94% of votes cast; 1,828,465 broker non-votes.","Grant Thornton ratified as auditor for FY2025 with 2,330,465 votes for, 40,532 against.","2020 Plan amendment approved with 387,895 for, 152,069 against; shares available increased to 1,023,017.","Non-binding say-on-pay passed with 474,987 for (87% of votes cast).","Stockholders preferred 3-year say-on-pay frequency (276,177 votes); board adopted triennial vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-006985","json":"https://secwatch.observer/filing/0001683168-25-006985.json","markdown":"https://secwatch.observer/filing/0001683168-25-006985.md","text":"https://secwatch.observer/filing/0001683168-25-006985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006985/0001683168-25-006985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316825006985/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:37:21.477348+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}